T. Rowe Price Associates’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,132
| Closed | -$5K | – | 2947 |
|
|
2023
Q1 | $5K | Hold |
1,132
| – | – | ﹤0.01% | 2899 |
|
|
2022
Q4 | $3K | Buy |
1,132
+534
| +89% | +$1.42K | ﹤0.01% | 2921 |
|
|
2022
Q3 | $3K | Sell |
598
-2,380
| -80% | -$11.9K | ﹤0.01% | 2938 |
|
|
2022
Q2 | $79K | Buy |
2,978
+32
| +1% | +$849 | ﹤0.01% | 2798 |
|
|
2022
Q1 | $110K | Buy |
2,946
+134
| +5% | +$5K | ﹤0.01% | 2824 |
|
|
2021
Q4 | $165K | Buy |
2,812
+950
| +51% | +$55.7K | ﹤0.01% | 2797 |
|
|
2021
Q3 | $153K | Sell |
1,862
-30
| -2% | -$2.47K | ﹤0.01% | 2769 |
|
|
2021
Q2 | $179K | Buy |
1,892
+575
| +44% | +$54.4K | ﹤0.01% | 2748 |
|
|
2021
Q1 | $84K | Buy |
+1,317
| New | +$84K | ﹤0.01% | 2788 |
|